Short answer: it depends entirely on what type your mother had — that’s the first question to answer, not whether to screen yourself.
The type of thyroid cancer changes everything
Thyroid cancer isn’t one disease genetically. Medullary thyroid cancer (MTC) is strongly hereditary, frequently linked to specific RET gene mutations, and when a family has a confirmed case, genetic testing for at-risk relatives is standard practice — not optional, not a judgment call.
The far more common types — papillary and follicular thyroid cancer, together over 90% of all cases — don’t follow that same clear single-gene inheritance pattern. But having one affected first-degree relative still meaningfully raises your own relative risk, commonly cited at roughly 8-10 times the general population rate. That figure comes from secondary sources summarizing case-series data rather than one large, definitive pooled study, so treat it as directionally real rather than a precise number.
The single most useful thing you can do right now is find out which type your mother had — it determines whether you’re in “get genetic testing” territory or “have a conversation with your doctor” territory.
Why guidelines still don’t recommend routine screening
Even with that elevated relative risk, major guidelines are consistent: the USPSTF recommends against thyroid cancer screening in average-risk adults (a Grade D recommendation), and explicitly lists a first-degree relative with thyroid cancer as a risk factor without converting that into a screening mandate. The American Cancer Society takes a middle position — screening “may be discussed” with your healthcare team if a parent, sibling, or child had thyroid cancer, which is a real conversation worth having, not something to dismiss, but also not an automatic yearly-ultrasound program.
This isn’t guidelines downplaying your risk — it reflects that thyroid cancer, especially the papillary type, is generally slow-growing and highly treatable, and that population-wide screening of relatives hasn’t been shown to improve outcomes enough to outweigh the downsides of finding and treating very small, often harmless nodules.
Does it matter how many relatives are affected?
Yes, substantially. One review found the probability that a case is genuinely familial non-medullary thyroid cancer rises from 31-38% with two affected first-degree relatives to over 95% with three or more. One affected parent is a real signal worth discussing — but it’s a meaningfully weaker one than if, say, a sibling is affected too.
What to actually do
- Find out your mother’s specific diagnosis — medullary vs. papillary/follicular. This single piece of information determines the next step.
- If medullary: ask your doctor about genetic testing (RET mutation analysis) directly — this is standard, not something you need to request apologetically.
- If papillary or follicular: raise it with your doctor as a “may be discussed” conversation per ACS guidance — mention the family history explicitly, since it may not come up otherwise, and ask whether a baseline thyroid exam or ultrasound makes sense for you specifically.
Getting Started
The family history alone isn’t a diagnosis or a mandate — it’s information that should shape a conversation with a doctor, starting with the one question that actually matters: what type did your mother have? See verified endocrinology clinics in Turkey, or ask our AI assistant if you want help thinking through what to ask.
Sources:
- Familial Non-Medullary Thyroid Carcinoma: A Case Series with Meta-Review — Lab Medicine
- Screening for Thyroid Cancer — US Preventive Services Task Force
- Can Thyroid Cancer Be Found Early? — American Cancer Society
- Relationship Between Affected Family Members and Clinical Aggressiveness in Familial Non-Medullary Thyroid Carcinoma — Endocrine (2025)